ETHealthworld.com |
Lynparza significantly reduces the risk of disease worsening in patients with BRCA mutations - study
ETHealthworld.com Lynparza significantly reduces the risk of disease worsening in patients with BRCA mutations - study AstraZeneca today presented positive results from its Phase III OlympiAD trial that showed a statistically-significant and clinically-meaningful ... |
from Health - Google News http://ift.tt/2qUv8lQ
EmoticonEmoticon